MTOR inhibitor 9a
This compound, a potent mTOR inhibitor, exhibits an IC50 of 80 nM against human LNCaP prostate cancer cell growth in vitro. Its antitumor potential is supported by research into mTOR pathway biology and oncology, suggesting utility in both cellular and preclinical animal studies.
Product Specifications
CAS Number
1144075-32-0
Product Name Alternative
1methyl3{4[4 (8oxa3azabicyclo[3.2.1]oct3yl) thieno[3,2d]pyrimidin2yl]phenyl}urea, mTOR inhibitor 9a
Field of Research
Pharmacology & Drug Discovery; Cell Biology
Purity
99.75% (May vary between batches)
Solubility
DMSO:12 mg/mL (30.34 mM)
Smiles
N (C (NC) =O) C1=CC=C (C2=NC (=C3C (=N2) C=CS3) N4CC5OC (C4) CC5) C=C1
Molecular Formula
C20H21N5O2S
Molecular Weight
395.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
244224 50 µL
CAPZB (Capping Protein (Actin Filament) Muscle Z-line, beta, CAPB, CAPPB, CAPZ, MGC104401, MGC129749, MGC129750)
Sign In for Pricing
View Details 